Commenters Question Rationale for GLP-1, Marketing Review, Prior Auth Proposals

  • Feb 06, 2025

    More than 4,000 stakeholders as of the Jan. 27 deadline had submitted feedback on a 700-plus page rule concerning the Medicare Advantage and Part D programs. Introduced by CMS under then-President Joe Biden, the proposed rule sought changes to marketing and communications, prescription drug coverage, health equity, utilization management and other aspects of MA and Part D. Some industry stakeholders took the opportunity to sound off on aspects of the program that weren’t addressed in the rulemaking, while others echoed the Donald Trump administration’s “Make America Healthy Again” rhetoric.

    Better for Medicare Alliance (BMA), for one, urged the new administration to put off finalizing the rule while also delaying CMS’s previously announced plans to end the MA Value-Based Insurance Design (VBID) model at the end of this year.

    Read more
    © 2024 MMIT
  • Lauren Flynn Kelly

    Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

The Latest
Meet Our Reporters

Meet Our Reporters

×